B
1.02
-0.06 (-5.56%)
| 前收盘价格 | 1.08 |
| 收盘价格 | 1.11 |
| 成交量 | 1,213,130 |
| 平均成交量 (3个月) | 957,259 |
| 市值 | 20,288,616 |
| 市盈率 (P/E TTM) | 11.33 |
| 价格/销量 (P/S) | 6.28 |
| 股市价格/股市净资产 (P/B) | 8.50 |
| 52周波幅 |
| 营业毛利率 | 4.28% |
| 营业利益率 (TTM) | -11.31% |
| 稀释每股收益 (EPS TTM) | 0.090 |
| 季度收入增长率 (YOY) | -1.00% |
| 季度盈利增长率 (YOY) | -36.70% |
| 总债务/股东权益 (D/E MRQ) | 74.26% |
| 流动比率 (MRQ) | 1.88 |
| 营业现金流 (OCF TTM) | -1.42 M |
| 杠杆自由现金流 (LFCF TTM) | 11.22 M |
| 资产报酬率 (ROA TTM) | -1.21% |
| 股东权益报酬率 (ROE TTM) | 6.10% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Care Facilities (US) | 混合的 | 混合的 |
| Medical Care Facilities (全球的) | 混合的 | 混合的 | |
| 股票 | Basel Medical Group Ltd | - | - |
AIStockmoo 评分
1.3
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.25 |
|
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore. |
|
| 部门 | Healthcare |
| 行业 | Medical Care Facilities |
| 内部持股比例 | 67.81% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合